CTOs on the Move

Nanoscope Therapeutics

www.nanostherapeutics.com

 
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is an independently held healthcare company dedicated to being a customer focused and innovative partner, providing medication management and clinical services in a caring, cost-effective, supportive environment, keeping patients healthier longer

Steele

Surgical Team

Surgical Team is a Key Biscayne, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Unistrut Corporation a division of Tyco

Unistrut Corporation a division of Tyco is a Wayne, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Virginia Premier Health Plan Inc

Virginia Premier Health Plan, Inc. is a Health Maintenance Organization (HMO, IPA model), which began operations as a full service Medicaid HMO in August 1995. VPHP is contracted with the Virginia Department of Medical Assistance Services to provide